Effects of hematopoietic growth factors on chemotherapy-induced myelosuppression.
Biesma
B
B
Department of Internal Medicine, University Hospital Groningen, The Netherlands.
Vellenga
E
E
Willemse
P H
PH
de Vries
E G
EG
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001855:Bone Marrow Diseases / Q000139:chemically induced / Q000188:drug therapy*; D004921:Erythropoietin / Q000627:therapeutic use; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use*; D006801:Humans; D007376:Interleukin-2 / Q000494:pharmacology; D016173:Macrophage Colony-Stimulating Factor / Q000627:therapeutic use
D000970:Antineoplastic Agents; D016298:Hematopoietic Cell Growth Factors; D007376:Interleukin-2; D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor; D016173:Macrophage Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor